Cancer diagnosis using smartphone attracts investors

5 June, 2018

Already a couple of days after the visit to the health centre, dangerous skin changes can be removed with an operation – if Gnosco’s digital diagnostic support is used. There is now a growing interest from investors who see a market for new ways to work in healthcare. This gives Sahlgrenska Science Park company, Gnosco, the opportunity for international growth.

 Early detection of dangerous skin changes saves lives. At the same time, millions can be saved in healthcare using a smartphone and Gnosco’s digital diagnostic support system, Dermicus.

“The market is rapidly moving into a mature phase with a strong trend towards digital healthcare services. We are ready to scale up. We are seeing good growth right now,” says Daniel Eliasson, CEO of Gnosco.

Almi Invest West Sweden, Västkusten affärsänglar (West Coast business angels) and some private investors are now injecting capital into the company for increased market efforts in the Nordic countries and an establishment in the UK.

 “It’s great that we can now focus on growth and also gain experience and knowledge through the new owners. It’s clear proof that we have something big going on,” says Daniel Eliasson.

 “Digital decision support for the healthcare sector is generally underdeveloped in the world. At the same time, there is a huge change in the industry right now. In Sweden, we have good prospects to expand globally with new types of digital services in healthcare. Gnosco has developed a unique product with many application areas and is well positioned for an international market, “says Mats Enegren of Almi Invest.

 Gnosco is driving several interesting development projects within AI, which are also expected to result in new services to make healthcare more efficient. However, Dermicus’s diagnosis support already saves a lot of money for the healthcare sector and gives many people greater chances of survival as they don’t have to wait unnecessarily to meet a dermatologist in person.

At the same time, things are made easier for primary care doctors who in short space of time need to make difficult diagnosis decisions about life-threatening diseases – without having specialist skills themselves.

In the Swedish primary care system, more than 150,000 assessments of skin changes are made every year to find around 4,000 cases of malignant melanoma.

“With our diagnostic support, the number of operations can decrease by 40 percent. Many interventions can be done directly at the health centre as long as the doctors know when to operate and what they should not remove,” says Daniel Eliasson.

General practitioners at the health centre photograph skin changes in the patient using a safe and simple mobile app and accompanying dermatoscope (a kind of magnifying glass with special light). The images are then available for dermatologists who can make a remote assessment and write a recommendation for managing the patient.